A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)
- Status
- COMPLETED
- Phase
- PHASE1
TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Long-Term Extension Study of WA22763 and NA25220 of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)
- Status
- COMPLETED
- Phase
- PHASE3
An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A
A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
- Status
- COMPLETED
- Phase
- PHASE4
Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease
- Status
- TERMINATED
- Phase
- PHASE2
Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab
- Status
- COMPLETED
- Phase
- PHASE4
Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488
- Status
- COMPLETED
- Phase
- PHASE4
A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy
- Status
- COMPLETED
- Phase
- N/A
An Open-Label Trial of Tocilizumab in Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE1